Testing effectiveness (Phase 2)Study completedNCT04681131What this trial is testingCAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLCWho this might be right forNon-Small-Cell Lung Cancer BioAtla, Inc. 85
Testing effectiveness (Phase 2)Study completedNCT01635270What this trial is testingPhase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung CarcinomaWho this might be right forNon-small Cell Lung CancerRadiation TherapyLocally Advanced Disease+2 more Centre Leon Berard 54
Testing effectiveness (Phase 2)Looking for participantsNCT07603856What this trial is testingA Study Evaluating The Combination of Immunotherapy With Radiotherapy in Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung CancerMetastatic Lung Cancer University of Chicago 39
Testing effectiveness (Phase 2)Active Not RecruitingNCT06188702What this trial is testingS095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAPWho this might be right forMTAP-deleted Solid Tumors Servier Bio-Innovation LLC 60
Testing effectiveness (Phase 2)Looking for participantsNCT03808337What this trial is testingInvestigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseaseWho this might be right forTriple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more Memorial Sloan Kettering Cancer Center 145
Large-scale testing (Phase 3)Study completedNCT02395172What this trial is testingAvelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)Who this might be right forCarcinoma, Non-Small-Cell Lung EMD Serono Research & Development Institute, Inc. 792
Not applicableActive Not RecruitingNCT04994795What this trial is testingPredictive Multimodal Signatures Associated With Response to Treatment and Prognosis of Patients With Stage IV Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Metastatic Sophia Genetics SAS 4,000
Large-scale testing (Phase 3)Study completedNCT00002930What this trial is testingPET Scan in Patients With Lung and Esophageal Cancers That May Be Removed by SurgeryWho this might be right forEsophageal CancerLung Cancer Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT07703228What this trial is testingSecond-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLCWho this might be right forNSCLC (Advanced Non-small Cell Lung Cancer)NSCLC Stage IIIB~IVSecond-line Therapy+1 more Nanfang Hospital, Southern Medical University 38
Early research (Phase 1)WithdrawnNCT00017537What this trial is testingVaccine Therapy in Treating Patients With Metastatic or Recurrent CancerWho this might be right forBreast CancerGastric CancerLung Cancer+2 more University of Alabama at Birmingham
Large-scale testing (Phase 3)Looking for participantsNCT06970639What this trial is testingA Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Sensitizing Mutation-Positive Non-squamous Non-Small Cell Lung Cancer (NSCLC) and Brain MetastasesWho this might be right forNSCLC Patients With Brain Metastasis Allist Pharmaceuticals, Inc. 380
Not applicableStudy completedNCT00460356What this trial is testingGlycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph NodesWho this might be right forCervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Small Cell Carcinoma+6 more Gynecologic Oncology Group 159
Testing effectiveness (Phase 2)Study completedNCT00088556What this trial is testingCarboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell Lung Telik 100
Early research (Phase 1)Study completedNCT04423029What this trial is testingDF6002 Alone and in Combination With NivolumabWho this might be right forSolid Tumors Dragonfly Therapeutics 170
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07271602What this trial is testingRandomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.Who this might be right forNon Small Cell Lung CancerImmunotherapyRadiotherapy+1 more Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 104
Early research (Phase 1)Study completedNCT02309177What this trial is testingSafety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast CancerWho this might be right forBreast NeoplasmsPancreatic Neoplasms Celgene 114
Not applicableLooking for participantsNCT06109454What this trial is testingObservation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical SurgeryWho this might be right forNon-small Cell Lung Cancer Liaoning Cancer Hospital & Institute 240
Testing effectiveness (Phase 2)Ended earlyNCT02488694What this trial is testingMaintaining ERBB Blockade in EGFR-mutated Lung CancerWho this might be right forNon-small-cell Lung Cancer With Somatic EGFR Mutations AIO-Studien-gGmbH 4
Testing effectiveness (Phase 2)Ended earlyNCT01578551What this trial is testingStudy of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma.Who this might be right forCarcinoma, Non-Small-Cell LungLung Adenocarcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Study completedNCT00050830What this trial is testingA Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung CancerWho this might be right forLung Neoplasms Pfizer 163